Dhanapalan Nagarathnam

Dhanapalan Nagarathnam is currently the President & CEO of MediVedaN Therapeutics, focusing on new drug discovery in various areas. Dhanapalan is also the President and CEO of DNSK International, LLC., collaborating with various organizations in drug discovery. With extensive experience in medicinal chemistry and drug development, Dhanapalan has held positions in companies like Bayer Health Care and Synaptic Pharmaceutical Corporation. Nagarathnam holds a Ph.D. in Organic/Medicinal Chemistry and has completed postdoctoral studies in Medicinal Chemistry.